Kidney Health Research Collaborative, Department of Medicine.
Department of Medicine, University of California San Francisco.
AIDS. 2023 Dec 1;37(15):2339-2348. doi: 10.1097/QAD.0000000000003705. Epub 2023 Aug 24.
People with HIV (PWH) generally have worse ambulatory levels of kidney injury biomarkers and excess risk of acute kidney injury (AKI) compared to persons without HIV. We evaluated whether ambulatory measures of subclinical kidney injury among PWH are associated with subsequent AKI.
In the Predictors of Acute Renal Injury Study (PARIS), which enrolled 468 PWH from April 2016 to August 2019, we measured 10 urine biomarkers of kidney health (albumin, a1m, b2M, NGAL, IL18, KIM-1, EGF, UMOD, MCP-1, YKL40) at baseline and annually during follow-up. Using multivariable Cox regression models, we evaluated baseline and time-updated biomarker associations with the primary outcome of AKI (≥0.3 mg/dl or ≥1.5-times increase in serum creatinine from baseline) and secondary outcome of all-cause hospitalization.
At baseline, the mean age was 53 years old, and 45% self-identified as female. In time-updated models adjusting for sociodemographic factors, comorbidities, albuminuria, estimated glomerular filtration rate, and HIV-associated factors, higher KIM-1 [hazard ratio (HR) = 1.30 per twofold higher; 95% confidence interval (CI) 1.03-1.63] and NGAL concentrations (HR = 1.24, 95% CI 1.06-1.44) were associated with higher risk of hospitalized AKI. Additionally, in multivariable, time-updated models, higher levels of KIM-1 (HR = 1.19, 95% CI 1.00, 1.41), NGAL (HR = 1.13, 95% CI 1.01-1.26), and MCP-1 (HR = 1.20, 95% CI 1.00, 1.45) were associated with higher risk of hospitalization.
Urine biomarkers of kidney tubular injury, such as KIM-1 and NGAL, are strongly associated with AKI among PWH, and may hold potential for risk stratification of future AKI.
与未感染 HIV 的人相比,HIV 感染者(PWH)的活动期肾损伤生物标志物水平通常更差,急性肾损伤(AKI)风险更高。我们评估了 PWH 活动期亚临床肾损伤的测量值是否与随后的 AKI 相关。
在 2016 年 4 月至 2019 年 8 月期间,预测急性肾损伤研究(PARIS)招募了 468 名 PWH,我们在基线和随访期间每年测量 10 种尿液肾健康生物标志物(白蛋白、a1m、b2M、NGAL、IL18、KIM-1、EGF、UMOD、MCP-1、YKL40)。我们使用多变量 Cox 回归模型评估了基线和时间更新的生物标志物与 AKI(≥0.3mg/dl 或基线时血清肌酐增加≥1.5 倍)和全因住院的次要结局的主要结局的相关性。
在基线时,平均年龄为 53 岁,45%的人自我认定为女性。在调整社会人口因素、合并症、白蛋白尿、估计肾小球滤过率和 HIV 相关因素的时间更新模型中,更高的 KIM-1[风险比(HR)=每增加两倍 1.30;95%置信区间(CI)1.03-1.63]和 NGAL 浓度(HR=1.24,95%CI 1.06-1.44)与住院 AKI 风险增加相关。此外,在多变量、时间更新模型中,更高水平的 KIM-1(HR=1.19,95%CI 1.00,1.41)、NGAL(HR=1.13,95%CI 1.01-1.26)和 MCP-1(HR=1.20,95%CI 1.00,1.45)与住院风险增加相关。
尿液肾管状损伤生物标志物,如 KIM-1 和 NGAL,与 PWH 的 AKI 密切相关,可能具有预测未来 AKI 的风险分层的潜力。